Novo Nordisk A/S (NVO) paid $1.80 in dividends per share over the trailing twelve months. The 5-year dividend CAGR is +10.58%.
NVO Annual Dividends per Share (Dividend History)
This step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency (typically quarterly or semi-annually).
Annual Dividend History List
| Payment Date | Nominal Dividend / Share | Distribution Change |
|---|---|---|
| Mar 30, 2026 | $1.22 | +108.34% Hike |
| Aug 18, 2025 | $0.58 | -48.86% Cut |
| Mar 31, 2025 | $1.14 | +121.04% Hike |
| Aug 16, 2024 | $0.52 | -44.38% Cut |
| Mar 22, 2024 | $0.93 | +112.09% Hike |
| Aug 18, 2023 | $0.44 | -25.77% Cut |
| Mar 24, 2023 | $0.59 | +104.34% Hike |
| Aug 12, 2022 | $0.29 | -43.49% Cut |
| Mar 25, 2022 | $0.51 | +85.80% Hike |
| Aug 16, 2021 | $0.28 | -40.32% Cut |
| Mar 26, 2021 | $0.46 | +78.09% Hike |
| Aug 14, 2020 | $0.26 | -33.84% Cut |
| Mar 27, 2020 | $0.39 | +74.13% Hike |
| Aug 16, 2019 | $0.22 | -42.16% Cut |
| Mar 22, 2019 | $0.39 | +68.07% Hike |
| Aug 17, 2018 | $0.23 | -42.64% Cut |
| Mar 23, 2018 | $0.40 | +70.10% Hike |
| Aug 17, 2017 | $0.24 | -29.32% Cut |
| Mar 23, 2017 | $0.34 | +47.83% Hike |
| Aug 11, 2016 | $0.23 | -52.67% Cut |
| Mar 18, 2016 | $0.48 | +31.26% Hike |
| Mar 19, 2015 | $0.36 | -12.08% Cut |
| Mar 21, 2014 | $0.42 | +33.84% Hike |
| Mar 21, 2013 | $0.31 | +23.60% Hike |
| Mar 22, 2012 | $0.25 | +33.06% Hike |
| Mar 24, 2011 | $0.19 | +38.76% Hike |
| Mar 25, 2010 | $0.14 | +25.21% Hike |
| Mar 19, 2009 | $0.11 | +15.20% Hike |
| Mar 13, 2008 | $0.09 | +52.16% Hike |
| Mar 8, 2007 | $0.06 | +28.92% Hike |
| Mar 9, 2006 | $0.05 | +12.07% Hike |
| Mar 10, 2005 | $0.04 | +18.48% Hike |
| Mar 17, 2004 | $0.04 | +38.38% Hike |
| Mar 26, 2003 | $0.03 | +32.17% Hike |
| Mar 13, 2002 | $0.02 | +25.35% Hike |
| Mar 21, 2001 | $0.02 | +26.65% Hike |
| Mar 24, 2000 | $0.01 | +11.73% Hike |
| Mar 25, 1999 | $0.01 | +82.76% Hike |
| Mar 27, 1998 | $0.01 | +7.39% Hike |
| Apr 25, 1997 | $0.01 | +33.69% Hike |
| May 1, 1996 | $0.00 | +9.88% Hike |
| Apr 24, 1995 | $0.00 | +46.52% Hike |
| Apr 26, 1994 | $0.00 | -4.90% Cut |
| Apr 22, 1993 | $0.00 | +3.56% Hike |
| Apr 28, 1992 | $0.00 | -10.64% Cut |
| Apr 19, 1991 | $0.00 | -3.80% Cut |
| Apr 23, 1990 | $0.00 | +34.69% Hike |
| Apr 21, 1989 | $0.00 | -11.29% Cut |
| Apr 21, 1988 | $0.00 | +26.06% Hike |
| Apr 20, 1987 | $0.00 | -15.76% Cut |
| Apr 21, 1986 | $0.00 | +32.82% Hike |
| Apr 19, 1985 | $0.00 | — |
About Novo Nordisk A/S
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Maziar Mike Doustdar